Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials
- PMID: 20515970
- DOI: 10.1136/adc.2008.157024
Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials
Abstract
Objective: Search for evidence supporting target age, level of intervention and target values for low-density lipoprotein (LDL) cholesterol levels in children with familial hypercholesterolemia.
Design: Systematic review and meta-analysis. PubMed, Medline, CINAHL and Cochrane Reviews databases from 1966 to 2007 were searched for articles reporting statin therapy in children and adolescents aged 8-18 years. Retrieved articles were screened for double-blind randomised controlled trials (RCTs).
Results: Seven trials involving 884 patients met inclusion criteria. Meta-analysis findings showed significantly reduced total cholesterol, LDL cholesterol and apolipoprotein B, whereas high-density lipoprotein cholesterol and apolipoprotein A1 were significantly increased by statin therapy. Evidence on target level in children was limited to one study attainment of LDL cholesterol treatment target in 60% of the subjects in the treatment group and none in the placebo group reached their target LDL cholesterol. Evidence on the effect of statins on surrogate markers of atherosclerosis was limited to two studies (one RCT on the effect upon the carotid intima-media thickness (n=211; mean difference (MD) -0.01; 95% CI -0.03 to -0.00), and one showing that the mean absolute change in flow-mediated dilation after 28 weeks of statin treatment was significantly higher in the simvastatin group compared to placebo group (MD 2.7%; 95% CI 0.42 to 4.98).
Conclusions: There is no firm evidence regarding when to start statin treatment or what target LDL cholesterol level should be attained. Recent recommendations that favour statins as the first-line drug treatment for hypercholesterolemia are evidence based. Studying high-risk groups (obese or diabetic patients) and incorporating composite end points may help define treatment guidelines.
Similar articles
-
Statins for children with familial hypercholesterolemia.Cochrane Database Syst Rev. 2017 Jul 7;7(7):CD006401. doi: 10.1002/14651858.CD006401.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Nov 7;2019(11). doi: 10.1002/14651858.CD006401.pub5. PMID: 28685504 Free PMC article. Updated.
-
Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. doi: 10.3310/hta12210. Health Technol Assess. 2008. PMID: 18485273
-
Statins for the treatment of dementia.Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007514. doi: 10.1002/14651858.CD007514.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2014 Jul 08;(7):CD007514. doi: 10.1002/14651858.CD007514.pub3. PMID: 20687089 Updated.
-
Statins for children with familial hypercholesterolemia.Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006401. doi: 10.1002/14651858.CD006401.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2014 Jul 23;(7):CD006401. doi: 10.1002/14651858.CD006401.pub3. PMID: 20614444 Updated.
-
Statins for Smith-Lemli-Opitz syndrome.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013521. doi: 10.1002/14651858.CD013521.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373961 Free PMC article.
Cited by
-
Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.BMC Complement Altern Med. 2013 Jul 18;13:178. doi: 10.1186/1472-6882-13-178. BMC Complement Altern Med. 2013. PMID: 23866314 Free PMC article. Clinical Trial.
-
Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes.J Pediatr. 2018 Jun;197:140-146.e12. doi: 10.1016/j.jpeds.2017.11.059. Epub 2018 Feb 1. J Pediatr. 2018. PMID: 29395184 Free PMC article.
-
Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?Arq Bras Cardiol. 2018 Sep;111(3):356-361. doi: 10.5935/abc.20180155. Epub 2018 Aug 23. Arq Bras Cardiol. 2018. PMID: 30156604 Free PMC article.
-
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia.Pediatr Cardiol. 2011 Apr;32(4):433-41. doi: 10.1007/s00246-011-9885-z. Epub 2011 Jan 23. Pediatr Cardiol. 2011. PMID: 21259004 Free PMC article. Clinical Trial.
-
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Drug Des Devel Ther. 2011;5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13. Drug Des Devel Ther. 2011. PMID: 21792295 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous